Journals / Bezmiâlem Science / 2020 / Cilt: 8 - Sayı: 2

Evaluation of Retinopathy of Prematurity: Four-year Followup Study in a Newly Established Tertiary Neonatal Intensive Care Unit in Turkey

Prematüre Retinopatisinin Değerlendirilmesi: Türkiye’de Yeni Kurulan Yenidoğan Yoğun Bakım Ünitesinde Dört Yıllık Takip Çalışması

Pages
170–174
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The awareness of the risk factors and the complications of ROP will decrease the incidence of the disease in unexperienced and newly organized NICUs.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Retinopathy of prematurity (ROP) is one of the leading causes of childhood vision loss in both developed and developing countries.
📊
Key Findings & Data:Methods: Two-hundred and forty eight (33.9%) infants were enrolled in ROP screening between January 2012-January 2016.
💡
Conclusion & Impact:The awareness of the risk factors and the complications of ROP will decrease the incidence of the disease in unexperienced and newly organized NICUs.
🔬Design:Research Article
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Retinopathy of prematurity (ROP) is one of the leading causes of childhood vision loss in both developed and developing countries. In this study, we aimed to assess the results of ROP screening and treatment, and to evaluate the risk factors in our newly established unit. We also compared our data with other studies reported in Turkey. Methods: Two-hundred and forty eight (33.9%) infants were enrolled in ROP screening between January 2012-January 2016. The results of ROP screening and treatment, and the risk factors for ROP in infants followed up in a newly established neonatal intensive care unit were determined. Results: ROP was observed in 25.8% of premature infants in different stages and zones. In the logistic regression analysis, we found an increased risk of ROP development in those patients with the following risk factors: Low gestational age [p=0.0001, odds ratio (OR)=0.73], sepsis (p=0.003, OR=0.57), and bronchopulmonary dysplasia (p=0.0035, OR=0.41). Conclusion: Good antenatal care, improving unit conditions, and regular screening will decrease the ROP incidence in our facility to the level of developed countries. Hopefully, this will help to reduce the future sequelae of visual function loss in these patients. The awareness of the risk factors and the complications of ROP will decrease the incidence of the disease in unexperienced and newly organized NICUs.

Özet

Amaç: Prematüre retinopatisi (ROP) hem gelişmiş hem de gelişmekte olan ülkelerde çocukluk çağı görme kaybının önde gelen nedenlerinden biridir. Bu çalışmada, yeni kurulan ünitemizdeki ROP taraması ve tedavisinin sonuçlarını ve risk faktörlerini değerlendirmeyi amaçladık. Sonuçlarımızı Türkiye’de yapılan diğer çalışmalarla da karşılaştırdık.Yöntemler: Ocak 2012-Ocak 2016 tarihleri arasında iki yüz kırk sekiz (%33,9) bebek ROP taramasına dahil edildi. Yeni kurulan yoğun bakım ünitesinde takip edilen bebeklerde ROP tarama ve tedavi sonuçları ile risk faktörleri belirlendi.Bulgular: Prematüre bebeklerin %25,8’inde farklı evre ve bölgelerde ROP gözlendi. Lojistik regresyon analizinde, aşağıdaki risk faktörleri olan hastalarda artan ROP gelişme riski bulduk: Düşük gebelik yaşı (p=0,0001, OR=0,73), sepsis (p=0,003, OR=0,57) ve bronkopulmoner displazi (p=0,0035, OR=0,41).Sonuç: Doğum öncesi iyi bakım, ünite koşullarının iyileştirilmesi ve düzenli tarama, ünitemizdeki ROP insidansını gelişmiş ülkeler seviyesine ulaştıracaktır. Umut ediyoruz ki bu da hastalarda görme fonksiyonlarının gelecekteki sekelini azaltmaya yardımcı olacaktır. Risk faktörleri ve komplikasyonlarla ilgili farkındalığın artması özellikle deneyimsiz ve yeni kurulan yenidoğan yoğun bakım ünitelerinde hastalığın görülme sıklığını azaltacaktır.

🔖

Cite This Article

BAYRAKTAR, S., BAYRAKTAR, B. T., MERİÇ, Z., KOYTAK, İ. A. (2022). Evaluation of Retinopathy of Prematurity: Four-year Followup Study in a Newly Established Tertiary Neonatal Intensive Care Unit in Turkey. Bezmiâlem Science, Cilt: 8 - Sayı: 2, 170–174. https://ajindex.com/articles/464048

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Bas AY, Koc E, Dilmen U, ROP Neonatal Study Group. Incidence and severity of retinopathy of prematurity in Turkey. Br J Ophthalmol 2015;99:1311-4
  2. Broxterman EC, Hug DA. Retinopathy of prematurity: a review of current screening guidelines and treatment options. Missouri Medicine 2016;113:187-90
  3. Yonekawa Y, Thomas BJ, Thanos A, Tedorich B, Drense KA, Trese MT, et al. The cutting edge of Retinopathy of Prematurity care expanding the boundaries of diagnosis and treatment. Retina 2017;37:2208-25
  4. Sen P, Rao C, Bansal N. Retinopathy of Prematurity: An Update. Sci J Med & Vis Res Foun 2015;vol XXXIII:93-6
  5. Shah PK, Prabhu V, Karandikar SS, Ranjan R, Narendran V, Kalpana N. Retinopathy of prematurity: Past, present and future. World J Clin Pediatr 2016;5:35-46
  6. Zhu T, Zhang L, Zhao F, Qu Y, Mu D. Association of maternal hypertensive disorders with retinopathy of prematurity: A systematic review and meta-analysis. PLoS One 2017;12:e0175374
  7. Fang JL, Sorita A, Carey WA, Colby CE, Murad MH, Alahdab F. Interventions To Prevent Retinopathy of Prematurity: A Metaanalysis. Pediatrics 2016;137:e20153387
  8. Suelves AM, Shulman JP. Current screening and treatments in retinopathy of prematurity in the US. Eye and Brain 2016:837-43
  9. Yau GS, Lee JW, Tam VT, Liu CC, Yip S, Cheng E, et al. Incidence and Risk Factors of Retinopathy of Prematurity From 2 Neonatal Intensive Care Units in a Hong Kong Chinese Population. Asia Pac J Ophthalmol 2016;5:185-91
  10. Section on Ophthalmology American Academy of Pediatrics, American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus. Screening examination of premature infants for retinopathy of prematurity. Pediatrics 2006;117:572-6
  11. International Committee for the Classification Retinopathy of Prematurity. The international classification of retinopathy of prematurity. Arch Ophthalmol 2005;123:991-9
  12. Early Treatment for Retinopathy of Prematurity Cooperative Group. Final results of the early treatment for retinopathy of prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc 2004;102:233-50
  13. Goble RR, Jones HS, Fielder AR. Are we screening too many babies for retinopathy of prematurity? Eye 1997;11:509-14
  14. Gilbert C, Fielder A, Gordillo L, Quinn G, Semiglia R, Visintin P, et al. Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs. Pediatric